Altor Fund IV and Goldman Sachs Merchant Banking Division have partnered to acquire the majority of Hamlet Protein from Polaris Private Equity and the founder of the company, Ole. K. Hansen.
Hamlet Protein is a global provider of soy-based protein solutions used in high value-add animal feed for young animals. The company services more than 50 countries from its two production facilities in Horsens, Denmark, and Findlay, Ohio, USA.
“This is another important milestone for Hamlet Protein and we are very excited about our new partnership with Altor and Goldman Sachs Merchant Banking Division,” said Søren Munch, CEO of Hamlet Protein. “With the strong support of Altor and Goldman Sachs Merchant Banking Division we are uniquely positioned to accelerate the development and growth of Hamlet Protein and better service our customers and partners globally.”
“We believe that Hamlet Protein is ideally positioned to become the global champion within high-value-add young animal feed,” said Søren Johansen, partner at Altor Equity Partners.
“We see significant growth potential globally and are excited about partnering with Altor and the management team to support the company’s impressive growth trajectory both organically and through acquisitions,” said Michael Specht Bruun, managing director in the Merchant Banking Division of Goldman Sachs.
Closing of the transaction is subject to customary regulatory requirements and approvals.
William Blair acted as exclusive financial adviser to the selling shareholders. Nordea has provided debt financing for the transaction.
New shelter data casts doubt on whether the pet population and pet ownership are truly growing.
While the pandemic caused unprecedented suffering worldwide in 2020, the disruptions to dogs, cats and other pets adoption numbers may normalize in 2021.